Corient Private Wealth Portfolio holdings
AUM
$94.9B
This Quarter Return
+10.91%
1 Year Return
+16.56%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$54.4B
AUM Growth
+$54.4B
(+25%)
Cap. Flow
+$4.36B
Cap. Flow
% of AUM
8.02%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
2,381
New
251
Increased
1,095
Reduced
782
Closed
130
Top Buys
| 1 |
Microsoft
MSFT
|
$200M |
| 2 |
Apple
AAPL
|
$196M |
| 3 |
Amazon
AMZN
|
$161M |
| 4 |
Lockheed Martin
LMT
|
$124M |
| 5 |
Zoetis
ZTS
|
$119M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$106M |
| 2 |
Vanguard S&P 500 Growth ETF
VOOG
|
$104M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
$103M |
| 4 |
iShares Russell 3000 ETF
IWV
|
$93.6M |
| 5 |
iShares Russell 2000 Growth ETF
IWO
|
$77.5M |
Sector Composition
| 1 | Technology | 19.12% |
| 2 | Financials | 13.28% |
| 3 | Healthcare | 10.73% |
| 4 | Industrials | 7.71% |
| 5 | Consumer Discretionary | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Potbelly
PBPB
$392M
| $104K | ﹤0.01% |
10,000
| – | – |
|
|
SVC
2152
Service Properties Trust
SVC
$451M
| $102K | ﹤0.01% |
11,894
| – | – |
|
2153
Avidity Biosciences
RNA
$5.99B
| $102K | ﹤0.01% |
11,220
-860
| -7% | -$7.78K |
|
2154
Gerdau
GGB
$6.15B
| $101K | ﹤0.01% |
20,882
+1,100
| +6% | +$5.34K |
|
|
LAR
2155
Lithium Argentina AG
LAR
$555M
| $98.1K | ﹤0.01% |
+15,526
| New | +$98.1K |
|
2156
Motorcar Parts of America
MPAA
$288M
| $97.1K | ﹤0.01% |
10,399
-193
| -2% | -$1.8K |
|
2157
Repay Holdings
RPAY
$509M
| $94K | ﹤0.01% |
11,012
| – | – |
|
2158
Granite Ridge Resources
GRNT
$730M
| $93.7K | ﹤0.01% |
15,572
| – | – |
|
|
SYRS
2159
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $93.5K | ﹤0.01% |
12,000
-14,666
| -55% | -$114K |
|
2160
AirSculpt Technologies
AIRS
$403M
| $92.9K | ﹤0.01% |
12,400
| – | – |
|
2161
FibroGen
FGEN
$47.8M
| $90.5K | ﹤0.01% |
102,103
-942
| -0.9% | -$835 |
|
2162
Eterna Therapeutics
ERNA
$9.79M
| $90.2K | ﹤0.01% |
50,398
-914
| -2% | -$1.64K |
|
|
CRON
2163
Cronos Group
CRON
$996M
| $89.1K | ﹤0.01% |
42,645
-200
| -0.5% | -$418 |
|
|
DISH
2164
DELISTED
DISH Network Corp.
DISH
| $88.9K | ﹤0.01% |
15,402
-58,272
| -79% | -$336K |
|
|
ETW
2165
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$977M
| $84.7K | ﹤0.01% |
10,905
| – | – |
|
2166
Ouster
OUST
$1.65B
| $84K | ﹤0.01% |
10,955
| – | – |
|
2167
Precision BioSciences
DTIL
$57.8M
| $83K | ﹤0.01% |
227,521
+158,365
| +229% | +$57.8K |
|
2168
Hanesbrands
HBI
$2.23B
| $81.2K | ﹤0.01% |
18,206
-36,044
| -66% | -$161K |
|
2169
Pitney Bowes
PBI
$2.09B
| $78.7K | ﹤0.01% |
17,894
-608
| -3% | -$2.68K |
|
2170
Prospect Capital
PSEC
$1.38B
| $75.4K | ﹤0.01% |
12,586
+1,371
| +12% | +$8.21K |
|
|
FSCO
2171
FS Credit Opportunities Corp
FSCO
$1.49B
| $74.6K | ﹤0.01% |
13,158
| – | – |
|
|
ICAD
2172
DELISTED
iCAD Inc
ICAD
| $72.6K | ﹤0.01% |
+41,000
| New | +$72.6K |
|
2173
PureCycle Technologies
PCT
$2.57B
| $72K | ﹤0.01% |
17,785
| – | – |
|
2174
C4 Therapeutics
CCCC
$185M
| $71.7K | ﹤0.01% |
12,695
| – | – |
|
|
ONL
2175
Orion Office REIT
ONL
$167M
| $71.6K | ﹤0.01% |
+12,525
| New | +$71.6K |
|